BRAF and neoplasm: HT29 cell line does not harbor KRAS mutation, whereas the cell line harbors BRAF and PIK3CA, the most commonly altered genes in human CRC, mutations.32 For this reason, we cannot accurately judge the effects of Ab3‐8 on tumor growth of KRAS‐mutated cancer.